Сравнение
Buserelin vs. Sincalide
Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.
Идентичность
Категория
Исследования (прочее)
Исследования (прочее)
Номер CAS
57982-77-1
25126-32-3
Молекулярная масса
1239.42 g/mol
1143.29 g/mol
Период полувыведения
нет данных
нет данных
Последовательность
нет данных
Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2Механизм действия
Buserelin
Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.
Sincalide
Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).
Доказательная база
Наивысшая доказательность
РКИ на людях
Исследование на людях
Исследования
0
0
из них на людях
0
0
Зафиксированные эффекты
2
1
Открытые противоречия
0
0
Задокументированные нежелательные явления
1
1
Правовой статус
Полные записи
Frequently asked questions
- What is the difference between Buserelin and Sincalide?
- Buserelin is classified as "Исследования (прочее)", while Sincalide is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Buserelin or Sincalide?
- The highest available evidence level is "РКИ на людях" for Buserelin and "Исследование на людях" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Buserelin and Sincalide in Germany and the United States?
- Германия: Buserelin — Рецептурный, Sincalide — Неясно. США: Buserelin — Не одобрено, Sincalide — Рецептурный. These are factual summaries with source and review date on the individual pages.